Zepp Health Corporation, a global leader in smart wearables and health technology, recently received a notification from the New York Stock Exchange regarding non-compliance with trading price standards for its American depositary shares (ADSs). The Company has six months to regain compliance by maintaining a closing share price of at least US$1.00 per ADS over a consecutive 30 trading-day period.
To address this issue, Zepp Health is exploring various options, including a potential reverse share split, subject to board and shareholder approval. Despite the NYSE notice, the Company’s ordinary shares are not immediately affected, and its business operations and reporting obligations remain unchanged.
Zepp Health Corporation, traded under the ticker symbol ZEPP, is a prominent player in the global smart wearables and health technology sector. The Company’s brands, including Amazfit, Zepp Clarity, and Zepp Aura, cater to users looking to optimize their health, fitness, and wellness journeys. With a focus on providing actionable insights and guidance through its Zepp Digital Management Platform, Zepp has shipped over 200 million units to more than 90 countries worldwide.
While Zepp Health remains committed to addressing the compliance deficiency within the stipulated timeframe, investors are advised to consider the inherent risks and uncertainties associated with forward-looking statements. Factors such as market trends, competition, and regulatory policies could impact the Company’s performance. For more information on potential risks and updates on Zepp Health Corporation, please refer to the Company’s filings with the U.S. Securities and Exchange Commission.
For inquiries related to investor relations and media, please reach out to Zepp Health Corporation’s dedicated contacts in China. Grace Yujia Zhang can be contacted via email at [email protected] for investor inquiries, and Piacente Financial Communications can be reached at +86-10-6508-0677 or [email protected] for media inquiries.
In conclusion, Zepp Health Corporation’s focus on innovation, user-centric products, and global presence underscore its commitment to empowering users to lead healthier lives. Despite the recent NYSE notification, Zepp Health remains steadfast in its mission to deliver cutting-edge solutions and drive positive outcomes for its stakeholders.
Source link
